Evidence map›Paper›PMID 33240825›Full record

ArticleFrontiers in cellular and infection microbiology2020

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant

Sandip Mukherjee, Supratim Pradhan, Souradeepa Ghosh, Shyam Sundar, Shantanabha Das, Budhaditya Mukherjee, Syamal Roy

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. EXCLI journal · 2024
    Article
  4. Imipramine Administration inPharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among ClinicalFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sandip MukherjeeInfectious Disease and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Supratim PradhanSchool of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.
Souradeepa GhoshSchool of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.
Shyam SundarDepartment of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Shantanabha DasInfectious Disease and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Budhaditya MukherjeeInfectious Disease and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Syamal RoyInfectious Disease and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Indian Institute of Technology Kharagpur · INIndian Institute of Chemical Biology · INBanaras Hindu University · INNational Institute of Pharmaceutical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously we have shown that long term oral treatment of tricyclic-antidepressant-drug, imipramine, against experimental visceral leishmaniasis, results in clearance of organ parasites, regardless of input infection, either with antimony-sensitive (Sb

Indexed as

Leishmania donovaniLeishmaniasis, VisceralAnimalsAntimonyCricetinaeDrug ResistanceImipramineLiposomesMiceMice, Inbred BALB CSqualeneAntimonyImipramineLiposomesSqualeneantimony resistanceefficacyimipramineliposomevisceral leishmaniasis

Identifiers

PMID33240825
PMCPMC7683767
OpenAlexW3104451531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.